Fenova Renal Research Adds to Roster
Frenova Renal Research, a division of Fresenius Medical Care North America (FMCNA) and the contract clinical research services provider dedicated exclusively to renal research, has added an additional location to its roster of manged clinical research sites. The new capacity will enhance Frenova's ability to help clinical research sponsors enroll patients rapidly and streamline clinical trials.
"We look forward to managing this site and working alongside our new partner investigators. Increasing our network of investigators and pool of patients allows our clients to significantly accelerate their clinical trials designed to ultimately better the lives of those living with renal disease," said Kurt Mussina, vice president, FMCNA, and general manager, Frenova Renal Research. "Between 2016 and 2018, we reduced the time from clinical trial agreement to first-patient-first-visit by over 80 percent among the sites we manage."
Frenova's approach to site management reduces administrative burdens, thereby compressing timelines. This provides investigators at sites managed by Frenova the opportunity to enroll patients sooner and with greater efficiency than they would otherwise.
The Las Vegas site of Nevada Kidney Disease and Hypertension Centers contributes 24 physicians, 2,000 ESRD patients, and 15,000 CKD patients to the program.
For more information visit www.FrenovaRenalResearch.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
